NCT03101085 - S-Equol in Alzheimer's Disease 2 Trial | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 5, 2017

Primary Completion Date

March 1, 2021

Study Completion Date

March 1, 2021

Conditions

Alzheimer Disease

Interventions

DRUG

S-equol and Placebo

S-equol is an estrogen receptor β (ERβ) agonist. Provided in capsules. The placebo is a matched pill that cannot be distinguished from the active S-equol.

DRUG

Placebo and S-equol

S-equol is an estrogen receptor β (ERβ) agonist. Provided in capsules. The placebo is a matched pill that cannot be distinguished from the active S-equol.

Trial Locations (2)

66160

University of Kansas Medical Center, Kansas City

66205

Clinical and Translational Science Unit, Fairway